Cancer Genetics: Development and validity testing of a screening instrument for psychosocial problems

Cancer Genetics: Development and validity testing of a screening instrument for psychosocial problems - Development and validity testing of a screening instrument

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32510

Enrollment

180

Registered

2010-02-10

Start date

2009-11-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychosocial problems

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) between 18 and 70 years of age 2) in sufficient command of the Dutch language to complete the questionnaires 3) attendees of a second visit at the family cancer clinic because of increased risk of developing cancer due to hereditary predisposition

Exclusion criteria

Exclusion criteria: Those who not fulfill the inclusion criteria

Design outcomes

Primary

Measure	Time frame
The primary study parameters are the screening questionnaire and the results of the interview between the social worker and the counselee. The following information will be extracted from the medical records: demographic data, number of affected relatives, age at which (s)he was first confronted with cancer in the family, types of cancer in the family, age at genetic testing, genetic test results, and whether (s)he has ever been treated for cancer. Additionally, information will be collected on previous professional psychosocial treatment and history.	—

Measure

Time frame

The primary study parameters are the screening questionnaire and the results of the interview between the social worker and the counselee. The following information will be extracted from the medical records: demographic data, number of affected relatives, age at which (s)he was first confronted with cancer in the family, types of cancer in the family, age at genetic testing, genetic test results, and whether (s)he has ever been treated for cancer. Additionally, information will be collected on previous professional psychosocial treatment and history.

—

Countries

Netherlands

Outcome results